Skip to main content
Premium Trial:

Request an Annual Quote

Imperial College Spinout Licenses IP to Ion Torrent

Premium

DNA Electronics has licensed intellectual property to Ion Torrent Systems, the Imperial College London spinout said this week.

The licensing agreement is non-exclusive and worldwide, but the parties did not disclose further details.

According to DNA Electronics’ website, its IP portfolio includes the label-free pH-mediated detection of DNA and RNA using semiconductor chips, DNA sequencing using chip-based detection of hydrogen ions released from nucleotide incorporation, novel low-power electronic interfacing techniques, methods for on-chip nucleic acid amplification, and methods for on-chip detection of SNPs.

The company, known as DNAe, has developed a platform, called Genalysis, for real-time nucleic acid sequence detection at the point of care. The platform uses disposable lab-on-chip cartridges that include reagents, microfluidics, and low-power silicon biosensors. Test reactions are analyzed in real time using a portable handheld device.

Possible applications for Genalysis include infectious disease screening, pharmacogenomics personalized medicine, clinic and home-use diagnostics, hospital bedside screening, as well as on-the-spot testing in the agricultural and food industries, forensics, and biodefense, according to the firm.

DNAe’s R&D facilities are located at the Institute of Biomedical Engineering at Imperial College London, and it has commercial offices in London’s midtown. Its founder and CEO, Chris Toumazou, is a principal investigator at Imperial.

Last year, the company and Imperial partnered with Pfizer to test a prototype of its device for assessing genetic predisposition to adverse drug reactions, a £1.2 million ($1.9 million) project partially funded by the UK Government’s Technology Strategy Board.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.